These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 11079263)

  • 1. The role of the graft endothelium in transplant rejection: evidence that endothelial activation may serve as a clinical marker for the development of chronic rejection.
    Denton MD; Davis SF; Baum MA; Melter M; Reinders ME; Exeni A; Samsonov DV; Fang J; Ganz P; Briscoe DM
    Pediatr Transplant; 2000 Nov; 4(4):252-60. PubMed ID: 11079263
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of antibody reactivity to major histocompatibility complex (MHC) and non-MHC alloantigens on graft endothelial cells in heart allograft rejection.
    Derhaag JG; Duijvestijn AM; Damoiseaux JG; van Breda Vriesman PJ
    Transplantation; 2000 May; 69(9):1899-906. PubMed ID: 10830229
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adhesion molecules (E-selectin and ICAM-1) in pulmonary allograft rejection.
    Shreeniwas R; Schulman LL; Narasimhan M; McGregor CC; Marboe CC
    Chest; 1996 Nov; 110(5):1143-9. PubMed ID: 8915211
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endothelial activation and chronic allograft rejection.
    Orosz CG
    Clin Transplant; 1994 Jun; 8(3 Pt 2):299-303. PubMed ID: 7520304
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The replacement of graft endothelium by recipient-type cells conditions allograft rejection mediated by indirect pathway CD4(+) T cells.
    Kapessidou Y; Habran C; Buonocore S; Flamand V; Barvais L; Goldman M; Braun MY
    Transplantation; 2006 Mar; 81(5):726-35. PubMed ID: 16534475
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of endothelial cells in allograft rejection.
    Rose ML
    Vasc Med; 1997; 2(2):105-14. PubMed ID: 9546952
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adhesion molecule P-selectin and vascular cell adhesion molecule-1 in enhanced heart allograft arteriosclerosis in the rat.
    Koskinen PK; Lemström KB
    Circulation; 1997 Jan; 95(1):191-6. PubMed ID: 8994436
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Propagation and characterization of lymphocytes from transplant biopsies.
    Duquesnoy RJ; Trager JD; Zeevi A
    Crit Rev Immunol; 1991; 10(6):455-80. PubMed ID: 1830745
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of ICAM-1 and VCAM-1 in renal allograft rejection.
    Jeong HJ; Lee HH; Kim YS; Kim SI; Moon JI; Park K
    Transplant Proc; 1998 Nov; 30(7):2953-4. PubMed ID: 9838302
    [No Abstract]   [Full Text] [Related]  

  • 10. The replacement of graft endothelium by recipient-type cells conditions allograft rejection mediated by indirect pathway CD4+ T cells.
    Kapessidou Y; Habran C; Buonocore S; Flamand V; Barvais L; Goldman M; Braun MY
    Transplantation; 2006 Aug; 82(4):582-91. PubMed ID: 16958183
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Temporal reduction in acute rejection after heart transplantation is not associated with a reduction in cell-mediated responses to donor-specific vascular endothelium.
    Hosenpud JD; Shipley GD; Mauck KA; Morris TE; Wagner CR
    J Heart Lung Transplant; 1995; 14(5):926-37. PubMed ID: 8800729
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sequential analysis of adhesion molecules and their ligands in rat renal allografts during the development of chronic rejection.
    Kauppinen H; Soots A; Krogerus L; Loginov R; Holma K; Ahonen J; Lautenschlager I
    Transpl Int; 2000; 13(4):247-54. PubMed ID: 10959476
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vascular endothelium does not activate CD4+ direct allorecognition in graft rejection.
    Kreisel D; Krasinskas AM; Krupnick AS; Gelman AE; Balsara KR; Popma SH; Riha M; Rosengard AM; Turka LA; Rosengard BR
    J Immunol; 2004 Sep; 173(5):3027-34. PubMed ID: 15322162
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mouse vascular endothelium activates CD8+ T lymphocytes in a B7-dependent fashion.
    Kreisel D; Krupnick AS; Balsara KR; Riha M; Gelman AE; Popma SH; Szeto WY; Turka LA; Rosengard BR
    J Immunol; 2002 Dec; 169(11):6154-61. PubMed ID: 12444119
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunopathology of cardiac transplant rejection.
    Duquesnoy RJ; Demetris AJ
    Curr Opin Cardiol; 1995 Mar; 10(2):193-206. PubMed ID: 7787286
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of adhesion molecules in chronic allograft rejection.
    Nowaczyk M; Górski A; Durlik M; Wyzgał J; Perkowska-Francka A
    Arch Immunol Ther Exp (Warsz); 1999; 47(6):373-5. PubMed ID: 10608294
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of vascular adhesion molecules during rejection of human cardiac allografts.
    Taylor PM; Rose ML; Yacoub MH; Pigott R
    Transplantation; 1992 Sep; 54(3):451-7. PubMed ID: 1384180
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endothelial cells as antigen-presenting cells: role in human transplant rejection.
    Rose ML
    Cell Mol Life Sci; 1998 Sep; 54(9):965-78. PubMed ID: 9791539
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peptides derived from alpha-helices of allogeneic class I major histocompatibility complex antigens are potent inducers of CD4+ and CD8+ T cell and B cell responses after cardiac allograft rejection.
    Shirwan H; Leamer M; Wang HK; Makowka L; Cramer DV
    Transplantation; 1995 Feb; 59(3):401-10. PubMed ID: 7871571
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Implications of de novo ELAM-1 and VCAM-1 expression in human cardiac allograft rejection.
    Ferran C; Peuchmaur M; Desruennes M; Ghoussoub JJ; Cabrol A; Brousse N; Cabrol C; Bach JF; Chatenoud L
    Transplantation; 1993 Mar; 55(3):605-9. PubMed ID: 7681227
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.